Superoxide dismutase - Ferring
Alternative Names: r-h CuZnSOD; Recombinant human copper zinc superoxide dismutase; SOD - FerringLatest Information Update: 07 Jan 2022
At a glance
- Originator Ferring Pharmaceuticals
- Class Anti-inflammatories; Anti-ischaemics; Antirheumatics; Oxidoreductases
- Mechanism of Action Superoxide dismutase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Neonatal respiratory distress syndrome
Most Recent Events
- 19 Sep 2006 Phase-II clinical trials in Neonatal respiratory distress syndrome in Switzerland (unspecified route)